Product
99mTc-3PRGD2
2 clinical trials
3 indications
Indication
Rheumatoid ArthritisIndication
lung cancerIndication
Lymph Node MetastasisClinical trial
Clinical Study of 99mTc-3PRGD2 SPECT/CT in Diagnosis and Efficacy Evaluation of Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2018-12-01
Clinical trial
Safety and Efficacy of 99mTc-hydrazinonicotinamide-PEG4-E[PEG4-c(RGDfk)]2 (99mTc-3PRGD2) for Integrin αVβ3 SPECT/CT Imaging of Lung Cancer and Mapping Lymph Node Metastases: A Prospective Multicenter, Self-controlled, Phase 3 TrialStatus: Completed, Estimated PCD: 2021-05-08